U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07260175) titled 'Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma' on Oct. 02.
Brief Summary: This study trial is a prospective, multicentre, exploratory, single-arm, open-label phase II study to evaluat ivosidenib maintenance after SOC adjuvant chemotherapy in curative mIDH1 cholangiocarcinoma
Study Start Date: Nov. 18
Study Type: INTERVENTIONAL
Condition:
Cholangiocarcinoma
IDH Mutation
Intervention:
DRUG: Ivosidenib
Ivosidenib (daily 500 mg) maintenance after SOC adjuvant chemotherapy in curative mIDH1 cholangiocarcinoma
Recruitment Status: RECRUITING
Sponsor: Institut f...